Gene editing, a set of techniques used to alter sections of an organism's DNA, is helping scientists cure diseases previously ...
Rapid advancements in CRISPR and next-generation gene editing technologies, combined with a strong clinical pipeline ...
The FDA last October paused Intellia Therapeutics’ late-stage CRISPR studies after detecting life-threatening enzyme ...
CRISPR isn't profitable, but it does have an approved gene therapy treatment with loads of potential.
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds. On February 17, ...
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first ...
Researchers at Vilnius University (Lithuania) have uncovered how the bacterial protein Cas9, better known as the CRISPR-Cas ...
Analysing the births of a Utah family over seven generations has revealed that their disproportionate number of boys could be ...
CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...
A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a ...
Protein activity can be precisely regulated via subtle changes in temperature using heat-sensitive switches. Underlying this ...
In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results